Services on Demand
Journal
Article
English (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Revista mexicana de neurociencia
On-line version ISSN 2604-6180Print version ISSN 1665-5044
Abstract
CHECA, Alejandro; NAVAS, Eliana; VALENCIA, Verónica and ALCIVAR, Jessica. Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador. Rev. mex. neurocienc. [online]. 2022, vol.23, n.4, pp.126-129. Epub Oct 07, 2022. ISSN 2604-6180. https://doi.org/10.24875/rmn.21000060.
Background:
Complications of COVID-19 can include neurological, psychiatric, psychological, and psychosocial sequelae. Little is known about the consequences of COVID-19 on the cognitive functions of patients in the subacute phase of the disease.
Objective:
The objective of the study was to determine if there is an incidence of cognitive impairment in patients with COVID-19 with mild to moderate symptoms in the remission phase.
Method:
This is a cross-sectional study conducted between April 2021 and August 2021 at the Eugenio Espejo Hospital in Quito, Ecuador. The Montreal Cognitive Assessment test was applied to COVID-19 patients with mild to moderate symptoms.
Results:
A total of 50 subjects were recruited, 88% (n = 44) presented cognitive deterioration and only 12% (n = 6) showed a normal score.
Conclusions:
In our cohort study, patients with COVID-19 with mild-moderate symptoms are at high risk of cognitive impairment.
Keywords : COVID-19; Cognitive impairment; Mild to moderate.
